$50.38-1.77% · 3M
Moving avg
1W-11.15%
1M-10.10%
3M-1.77%
6M+17.33%
YTD+15.60%
1Y+32.75%
3Y+134.22%
5Y+180.36%
52-week range
$33.7670% of range$57.57
Company health
Value2/6
Growth6/6
Profitability6/6
Health5/6
Dividend0/6
Bull vs bear
Strengths
- Strong 34% net margin
- High return on equity (4021%)
- Revenue compounding 51% a year
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$12.66B
Enterprise value
$13.76B
P/E ratio (TTM)
17.62x
P/S ratio (TTM)
5.82x
EV/EBITDA
13.56x
Per share & returns
EPS (TTM)
$3.23
Dividend yield
0.00%
Beta (1Y)
0.42
30-day change
-10.10%
Trading
Volume (24h)
2.91M
Previous close
$51.33
Shares outstanding
251.36M
About Exelixis, Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Symbol
EXEL
Exelixis, Inc. is a large-cap healthcare company in the Biotechnology industry. Its shares are listed on NASDAQ (United States) and trade under the ticker EXEL.
Frequently asked questions
What is Exelixis, Inc.'s market cap?
Exelixis, Inc. (EXEL) has a market capitalization of $12.66B.
What is Exelixis, Inc.'s P/E ratio?
Exelixis, Inc. trades at a price-to-earnings (P/E) ratio of 17.62.
What exchange does EXEL trade on?
EXEL trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,220.51+0.45%
$1.15T cap
Johnson & JohnsonJNJ
$260.86+0.41%
$628.65B cap
AbbVie Inc.ABBV
$248.66-0.57%
$439.33B cap
UnitedHealth Group IncorporatedUNH
$405.59+0.85%
$368.33B cap
Roche Holding AGSWX: ROP
CHF 364.40-0.30%
$356.38B cap
Merck & Co., Inc.MRK
$132.93+1.92%
$328.31B cap
Novartis AGSWX: NOVN
CHF 123.66-0.43%
$288.78B cap
AstraZeneca PLCLON: AZN
£116.42-0.51%
$243.38B cap